These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 29750030)

  • 1. Validation of exhaled volatile organic compounds analysis using electronic nose as index of COPD severity.
    Finamore P; Pedone C; Scarlata S; Di Paolo A; Grasso S; Santonico M; Pennazza G; Antonelli Incalzi R
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1441-1448. PubMed ID: 29750030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects.
    Besa V; Teschler H; Kurth I; Khan AM; Zarogoulidis P; Baumbach JI; Sommerwerck U; Freitag L; Darwiche K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():399-406. PubMed ID: 25759572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of volatile organic compounds: an innovative approach to heart failure characterization in older patients.
    Finamore P; Pedone C; Lelli D; Costanzo L; Bartoli IR; De Vincentis A; Grasso S; Parente FR; Pennazza G; Santonico M; Incalzi RA
    J Breath Res; 2018 Feb; 12(2):026007. PubMed ID: 29408802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
    Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
    Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
    Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
    Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease.
    Fens N; Roldaan AC; van der Schee MP; Boksem RJ; Zwinderman AH; Bel EH; Sterk PJ
    Clin Exp Allergy; 2011 Oct; 41(10):1371-8. PubMed ID: 21732998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of airway bacterial colonization by an electronic nose in Chronic Obstructive Pulmonary Disease.
    Sibila O; Garcia-Bellmunt L; Giner J; Merino JL; Suarez-Cuartin G; Torrego A; Solanes I; Castillo D; Valera JL; Cosio BG; Plaza V; Agusti A
    Respir Med; 2014 Nov; 108(11):1608-14. PubMed ID: 25269711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between COPD patients with and without alpha 1-antitrypsin deficiency using an electronic nose.
    Hattesohl AD; Jörres RA; Dressel H; Schmid S; Vogelmeier C; Greulich T; Noeske S; Bals R; Koczulla AR
    Respirology; 2011 Nov; 16(8):1258-64. PubMed ID: 21883674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
    Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
    J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study.
    van Velzen P; Brinkman P; Knobel HH; van den Berg JWK; Jonkers RE; Loijmans RJ; Prins JM; Sterk PJ
    COPD; 2019 Dec; 16(5-6):330-337. PubMed ID: 31588813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cluster analysis on breath print of newly diagnosed COPD patients: effects of therapy.
    Scarlata S; Finamore P; Santangelo S; Giannunzio G; Pennazza G; Grasso S; Santonico M; Incalzi RA
    J Breath Res; 2018 Jun; 12(3):036022. PubMed ID: 29724960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the Electronic Nose to Identify Airway Infection during COPD Exacerbations.
    Shafiek H; Fiorentino F; Merino JL; López C; Oliver A; Segura J; de Paul I; Sibila O; Agustí A; Cosío BG
    PLoS One; 2015; 10(9):e0135199. PubMed ID: 26353114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of inflammatory profile by breath analysis in chronic coronary syndromes.
    Segreti A; Incalzi RA; Lombardi M; Miglionico M; Nusca A; Pennazza G; Santonico M; Grasso S; Grigioni F; Di Sciascio G
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):675-681. PubMed ID: 32740499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial performance index correlates with the BODE index and affects quality of life in COPD patients.
    Tannus-Silva DG; Masson-Silva JB; Ribeiro LS; Conde MB; Rabahi MF
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2261-2268. PubMed ID: 27695314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease.
    Faganello MM; Tanni SE; Sanchez FF; Pelegrino NR; Lucheta PA; Godoy I
    Am J Med Sci; 2010 Jan; 339(1):10-4. PubMed ID: 19926966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD.
    Kerti M; Balogh Z; Kelemen K; Varga JT
    Int J Chron Obstruct Pulmon Dis; 2018; 13():717-724. PubMed ID: 29535512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.